Table of Contents

NEUROPHARMACOLOGY

• You have access

  [³H]RY 80: A High-Affinity, Selective Ligand for γ-Aminobutyric Acid_A Receptors ContainingAlpha-5 Subunits ^,

  Phil Skolnick, Rona J. Hu, Christine M. Cook, Stephen D. Hurt, Joseph D. Trometer, Ruiyan Liu, Qi Huang and James M. Cook

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 488-493;
• You have access

  Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing theDelta Opioid Receptor

  Mary J. Clark, Paul J. Emmerson, Alfred Mansour, Huda Akil, James H. Woods, Philip S. Portoghese, Ann E. Remmers and Fedor Medzihradsky

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 501-510;
• You have access

  The Role of Dopaminergic Systems in Opioid Receptor Desensitization in Nucleus Accumbens and Caudate Putamen of Rat After Chronic Morphine Treatment

  Florence Noble and Brian M. Cox

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 557-565;
• You have access

  In Vivo Criteria To Differentiate Monoamine Reuptake Inhibitors from Releasing Agents: Sibutramine Is a Reuptake Inhibitor

  C. Gundlah, K. F. Martin, D. J. Heal and S. B. Auerbach

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 581-591;
• You have access

  Exacerbation of Methamphetamine-Induced Neurochemical Deficits by Melatonin

  James W. Gibb, Lloyd Bush and Glen R. Hanson

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 630-635;
• You have access

  Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor

  Smita Patel, Stephen Freedman, Kerry L. Chapman, Frances Emms, Alan E. Fletcher, Mick Knowles, Rosemarie Marwood, George Mcallister, Jan Myers, Shil Patel, Neil Curtis, Jan J. Kulagowski, Paul D. Leeson, Mark Ridgill, Mike Graham, Steve Matheson, Denise Rathbone, Alan P. Watt, Linda J. Bristow, Nadia M. J. Rupniak, Elizabeth Baskin, Joseph J. Lynch and C. Ian Ragan

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 636-647;
• You have access

  Desensitization of a γ-Aminobutyric Acid Type A Receptor in Rat Is Increased by Chronic Treatment with Chlordiazepoxide: A Molecular Mechanism of Dependence

  Derek J. Cash, Peter Serfözö and Andrea M. Allan

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 704-711;
• You have access

  (S)-(−)-HA-966, a γ-Hydroxybutyrate-Like Agent, Prevents Enhanced Mesocorticolimbic Dopamine Metabolism and Behavioral Correlates of Restraint Stress, Conditioned Fear and Cocaine Sensitization

  Bret A. Morrow, Edward J. K. Lee, Jane R. Taylor, John D. Elsworth, Heather E. Nye and Robert H. Roth

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 712-721;
• You have access

  Binding and In Vitro Activities of Peptides with High Affinity for the Nociceptin/Orphanin FQ Receptor, ORL1

  Colette T. Dooley, Christine G. Spaeth, Ilona P. Berzetei-Gurske, Karen Craymer, Indira D. Adapa, Susan R. Brandt, Richard A. Houghten and Lawrence Toll

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 735-741;
• You have access

  4-Methylhomoibotenic Acid Activates a Novel Metabotropic Glutamate Receptor Coupled to Phosphoinositide Hydrolysis

  Dorothy S. Chung, Stephen F. Traynelis, T. J. Murphy and P. Jeffrey Conn

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 742-749;
• You have access

  Nicotinic-Receptor Mediation of S(-)Nornicotine-Evoked [³H]Overflow from Rat Striatal Slices Preloaded with [³H]Dopamine

  Lihong Teng, Peter A. Crooks, Susan T. Buxton and Linda P. Dwoskin

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 778-787;
• You have access

  Motor Response to a Dopamine D3 Receptor Preferring Agonist Compared to Apomorphine in Levodopa-Primed 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Monkeys

  P. J. Blanchet, S. Konitsiotis and T. N. Chase

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 794-799;
• You have access

  Differential Regulation of D₂ and D₄Dopamine Receptor mRNAs in the Primate Cerebral Cortexvs. Neostriatum: Effects of Chronic Treatment with Typical and Atypical Antipsychotic Drugs

  Michael S. Lidow and Patricia S. Goldman-Rakic

  Journal of Pharmacology and Experimental Therapeutics November 1997, 283 (2) 939-946;